Showing Results for
- Academic Journals (5,082)
Search Results
- 5,082
Academic Journals
- 5,082
- Search Terms:ISSN: 14786354AndISSN: 14786362AndVolume Number: 10 Suppl 2AndStart Page: S1AndDate: 2008 Revise Search
- 1From: Arthritis Research & Therapy. (Vol. 26, Issue 1) Peer-ReviewedObjectives Peptidoglycan (PG) is an arthritogenic bacterial cell wall component whose role in human osteoarthritis is poorly understood. The purpose of this study was to determine if PG is present in synovial tissue of...
- 2From: Arthritis Research & Therapy. (Vol. 21, Issue 1) Peer-ReviewedBackground Infectious agents have long been postulated to be disease triggers for systemic sclerosis (SSc), but a definitive link has not been found. Metagenomic analyses of high-throughput data allows for the unbiased...
- 3From: Arthritis Research & Therapy. (Vol. 21, Issue 1) Peer-ReviewedObesity is associated with numerous comorbidities including some rheumatic conditions. Through adipose-derived inflammation, obesity has been shown to induce increased initiation, progression, and worse responses on...
- 4From: Arthritis Research & Therapy. (Vol. 21, Issue 1) Peer-ReviewedBackground Glomerulonephritis is one of the major complications and causes of death in systemic lupus erythematosus (SLE) and is characterized by glomerulosclerosis, interstitial fibrosis, and tubular atrophy, along...
- 5From: Arthritis Research & Therapy. (Vol. 21, Issue 1) Peer-ReviewedBackground Antibodies and upregulated cytokines and chemokines predate the onset of rheumatoid arthritis (RA) symptoms. We aimed to identify the pathways related to the early processes leading to RA development, as...
- 6From: Arthritis Research & Therapy. (Vol. 22, Issue 1) Peer-ReviewedBackground The utility of generic health-related quality of life (HRQoL) questionnaires in patients with systemic lupus erythematosus (SLE) is uncertain. We compared the performance of generic (SF36) and specific...
- 7From: Arthritis Research & Therapy. (Vol. 21, Issue 1) Peer-ReviewedOver the past 20 years, the rheumatoid arthritis (RA) treatment landscape has been continuously evolving. A range of novel biologic agents, different from the conventional therapies, became available. However, some...
- 8From: Arthritis Research & Therapy. (Vol. 22, Issue 1) Peer-ReviewedBackground Systemic lupus erythematosus (SLE) is an autoimmune inflammatory rheumatic disease. SLE susceptibility is affected by multiple genetic elements, environmental factors, and their interactions. We aimed in...
- 9From: Arthritis Research & Therapy. (Vol. 22, Issue 1) Peer-ReviewedBackground The mechanisms involved in the pathogenesis of autoimmune disorders, including systemic lupus erythematosus (SLE), have not been fully elucidated. Some of these mechanisms involve epigenetic regulation of...
- 10From: Arthritis Research & Therapy. (Vol. 22, Issue 1) Peer-ReviewedBackground Juvenile idiopathic arthritis (JIA) is an umbrella term of inflammatory joint diseases in children. Oligoarthritis is the most common form in the Western world, representing roughly 60% of all patients....
- 11From: Arthritis Research & Therapy. (Vol. 22, Issue 1) Peer-ReviewedBackground Dual-energy CT (DECT) can acknowledge differences in tissue compositions and can colour-code tissues with specific features including monosodium urate (MSU) crystals. However, when evaluating gout patients,...
- 12From: Arthritis Research & Therapy. (Vol. 22, Issue 1) Peer-ReviewedBackground Patients with ankylosing spondylitis (AS) are at increased risk of depression. This increased risk has been hypothesized to be solely secondary due to AS-related symptoms, or additionally due to a common...
- 13From: Arthritis Research & Therapy. (Vol. 23, Issue 1) Peer-ReviewedBackground Limited information is available on the impact of treatment with a tumor necrosis factor inhibitor (TNFi) on structural lesions in patients with recent-onset axial spondyloarthritis (axSpA). We compared...
- 14From: Arthritis Research & Therapy. (Vol. 23, Issue 1) Peer-ReviewedBackground Vaspin is a novel anti-inflammatory adipokine associated with cardiovascular (CV) disease and inflammation in chronic inflammatory conditions different from axial spondyloarthritis (axSpA). Given the high...
- 15From: Arthritis Research & Therapy. (Vol. 23, Issue 1) Peer-ReviewedBackground Premature atherosclerosis occurs in patients with SLE; however, the mechanisms remain unclear. Both mitochondrial machinery and proinflammatory cytokine interferon alpha (IFN-[alpha]) potentially contribute...
- 16From: Arthritis Research & Therapy. (Vol. 23, Issue 1) Peer-ReviewedBackground In the pathogenesis of rheumatoid arthritis (RA), the role of mast cells has not been revealed clearly. We aimed to define the inflammatory and tissue-destructive roles of mast cells in rheumatoid arthritis...
- 17From: Arthritis Research & Therapy. (Vol. 23, Issue 1) Peer-ReviewedBackground Multimorbidity raises the number of essential information needed for delivery of high-quality care in patients with chronic diseases like rheumatoid arthritis (RA). We evaluated an innovative ICT platform...
- 18From: Arthritis Research & Therapy. (Vol. 23, Issue 1) Peer-ReviewedBackground Enthesitis is a hallmark of spondyloarthritis (SpA) with a substantial impact on quality of life. Reports of treatment effectiveness across individual enthesitis sites in real-world patients with axial SpA...
- 19From: Arthritis Research & Therapy. (Vol. 23, Issue 1) Peer-ReviewedObjectives Pain is a major symptom in patients with rheumatoid arthritis (RA). In early RA, pain is usually due to synovitis, but can also persist despite effective anti-inflammatory treatment. The objective of this...
- 20From: Arthritis Research & Therapy. (Vol. 23, Issue 1) Peer-ReviewedNew molecular mechanisms that can be targeted with specific drugs have recently emerged for the treatment of systemic sclerosis (SSc) patients. Over the past 3 years, the achievement of one large phase 3 trial has led to...